Rare diseases
Investigational molecules
Locations
Back to France1 490 clinical trials in Marseille, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy
FranceStudy of Niraparib and Dostarlimab for Children with Recurrent or Hard-to-Treat Solid Tumors
FranceStudy of Lenvatinib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Cancer After Platinum and Immunotherapy Treatment
FranceStudy on the Safety and Effectiveness of Vepdegestrant and PF-07220060 for Adults with ER+/HER2- Advanced or Metastatic Breast Cancer
FranceStudy on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
FranceStudy of Lacutamab Alone or with Chemotherapy for Patients with Advanced T-Cell Lymphoma
FranceStudy of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma
FranceStudy on Ribociclib, Alpelisib, and Letrozole for Adults with Advanced Hormone Receptor-Positive Breast Cancer
FranceStudy on the Effectiveness and Safety of L19TNF and Dacarbazine for Patients with Advanced or Metastatic Soft-Tissue Sarcoma After Previous Treatments
FranceStudy on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery
FranceStudy on the Safety and Effectiveness of Amivantamab and Capmatinib for Patients with Unresectable Metastatic Non-Small Cell Lung Cancer
FranceStudy of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant
FranceThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on innovative treatments for head and neck squamous cell carcinoma, examining novel therapies and combinations with radiotherapy. Research includes investigations into endometrial cancer and bladder cancer treatments.
Particular emphasis on combining immunotherapy with conventional treatments for improved patient outcomes.
Innovative research addressing heart failure prevention and treatment of acute myocardial infarction. Studies include new approaches for managing hypertriglyceridemia and chronic kidney disease.
Focus on developing novel therapeutic approaches and improving patient outcomes in cardiovascular health.
Clinical investigations into multiple sclerosis treatment strategies and management of essential tremor. Research includes innovative approaches for Dravet Syndrome and neurological disorders.
Emphasis on developing targeted therapies for various neurological conditions affecting both adults and children.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
